| Health / Medical Topics |
Thromboxane Degradation
Thromboxane Degradation consists of conjugation, transport, and/or oxidation of widely distributed compounds formed by cyclooxygenase from polyunsaturated fatty acid prostaglandin endoperoxides (thromboxanes) and have a regulatory effect on platelet aggregation, contraction of arteries, and other biological effects. (NCI Thesaurus)
YOU MAY ALSO LIKE
The determination of the amount of the thromboxane B2 in a sample.
An eicosanoid and biologically inactive metabolite of thromboxane A2. Thromboxane B2 is released during anaphylaxis. As thromboxane A2 has a short half-life,…
Through decreased production and release, or enhanced degradation, Thromboxane Activity Inhibition involves interference with, or restraint of, the biological function of widely…
Through increased production or release, or inhibited degradation, Thromboxane Activity Induction involves initiation of the biological function of widely distributed compounds formed…
Thromboxane A2 receptor (343 aa, ~37 kDa) is encoded by the human TBXA2R gene. This protein is involved in both the stimulation…
Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet…
